BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  EyePoint to Present at the 43rd Annual J.P. Morgan Healthcare Conference

  December 18, 2024

   · 

  2 min read
• Press Releases

  Kynexis Announces Positive Topline Results from Phase 1 Study of KYN-5356, a Potential Treatment for Cognitive Impairment Associated with Schizophrenia

  December 18, 2024

   · 

  3 min read
• Press Releases

  Press Release: Availability of the Q4 2024 Aide-mémoire

  December 18, 2024

   · 

  4 min read
• Press Releases

  LeMaitre Vascular Prices $150 Million Convertible Senior Notes

  December 18, 2024

   · 

  6 min read
• Press Releases

  Vizgen Launches Certified Service Provider (CSP) Program, Expanding Access to Single-Cell Spatial Genomics Technology

  December 18, 2024

   · 

  3 min read
• Press Releases

  EYLEA HD® (aflibercept) Injection 8 mg Phase 3 Trial Meets Primary Endpoint Showing Improved Vision with Extended Dosing Intervals in Patients with Macular Edema following Retinal Vein Occlusion

  December 18, 2024

   · 

  16 min read
• Press Releases

  BioCardia Announces Commercial Availability of Morph® DNA™ Steerable Introducer Product Family

  December 18, 2024

   · 

  3 min read
• Press Releases

  Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab

  December 18, 2024

   · 

  6 min read
• Press Releases

  Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial

  December 18, 2024

   · 

  7 min read
• Press Releases

  Affimed Reports Positive Clinical Update on AFM24/Atezolizumab Combination Therapy in Non-Small Cell Lung Cancer (NSCLC)

  December 18, 2024

   · 

  9 min read